Neuroprotective Role of Erythropoietin in Perinatal Asphyxia

• Status: Completed
• Trial end date: 2016-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Whether Erythropoietin improves the neurological outcomes of neonates with perinatal asphyxia.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sheri Kashmir Institute of Medical Sciences
• Treatments: Epoetin Alfa

Criteria

Inclusion Criteria:

• Babies with severe perinatal asphyxia with moderate to severe HIE in the immediate neonatal period

Exclusion Criteria:

• Babies with congenital malformations

• Small for gestational age babies

• Babies with chromosomal anomalies